JAK2 and leukemia: Additionally, we investigated how Lgl1 loss modified disease progression in leukaemia models driven by the commonly mutated oncogenes c-Myc and constitutively active JAK2 (in Eμ-Myc [23] and TEL-JAK2 [24] mice respectively).